Cargando…
Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model
The treatment for osteomyelitis consists of surgical debridement, filling of the dead space, soft tissue coverage, and intravenous administration of antimicrobial (AM) agents for long periods. Biomaterials for local delivery of AM agents, while providing controllable antibiotic release rates and sim...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952702/ https://www.ncbi.nlm.nih.gov/pubmed/36829700 http://dx.doi.org/10.3390/bioengineering10020206 |
_version_ | 1784893697389756416 |
---|---|
author | Alegrete, Nuno Sousa, Susana R. Padrão, Tatiana Carvalho, Ângela Lucas, Raquel Canadas, Raphael F. Lavrador, Catarina Alexandre, Nuno Gärtner, Fátima Monteiro, Fernando J. Gutierres, Manuel |
author_facet | Alegrete, Nuno Sousa, Susana R. Padrão, Tatiana Carvalho, Ângela Lucas, Raquel Canadas, Raphael F. Lavrador, Catarina Alexandre, Nuno Gärtner, Fátima Monteiro, Fernando J. Gutierres, Manuel |
author_sort | Alegrete, Nuno |
collection | PubMed |
description | The treatment for osteomyelitis consists of surgical debridement, filling of the dead space, soft tissue coverage, and intravenous administration of antimicrobial (AM) agents for long periods. Biomaterials for local delivery of AM agents, while providing controllable antibiotic release rates and simultaneously acting as a bone scaffold, may be a valuable alternative; thus, avoiding systemic AM side effects. V-HEPHAPC is a heparinized nanohydroxyapatite (nHA)/collagen biocomposite loaded with vancomycin that has been previously studied and tested in vitro. It enables a vancomycin-releasing profile with an intense initial burst, followed by a sustained release with concentrations above the Minimum Inhibitory Concentration (MIC) for MRSA. In vitro results have also shown that cellular viability is not compromised, suggesting that V-HEPHAPC granules may be a promising alternative device for the treatment of osteomyelitis. In the present study, V-HEPHAPC (HEPHAPC with vancomycin) granules were used as a vancomycin carrier to treat MRSA osteomyelitis. First, in vivo Good Laboratory Practice (GLP) toxicological tests were performed in a rabbit model, assuring that HEPHAPC and V-HEPHAPC have no relevant side effects. Second, V-HEPHAPC proved to be an efficient drug carrier and bone substitute to control MRSA infection and simultaneously reconstruct the bone cavity in a sheep model. |
format | Online Article Text |
id | pubmed-9952702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99527022023-02-25 Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model Alegrete, Nuno Sousa, Susana R. Padrão, Tatiana Carvalho, Ângela Lucas, Raquel Canadas, Raphael F. Lavrador, Catarina Alexandre, Nuno Gärtner, Fátima Monteiro, Fernando J. Gutierres, Manuel Bioengineering (Basel) Article The treatment for osteomyelitis consists of surgical debridement, filling of the dead space, soft tissue coverage, and intravenous administration of antimicrobial (AM) agents for long periods. Biomaterials for local delivery of AM agents, while providing controllable antibiotic release rates and simultaneously acting as a bone scaffold, may be a valuable alternative; thus, avoiding systemic AM side effects. V-HEPHAPC is a heparinized nanohydroxyapatite (nHA)/collagen biocomposite loaded with vancomycin that has been previously studied and tested in vitro. It enables a vancomycin-releasing profile with an intense initial burst, followed by a sustained release with concentrations above the Minimum Inhibitory Concentration (MIC) for MRSA. In vitro results have also shown that cellular viability is not compromised, suggesting that V-HEPHAPC granules may be a promising alternative device for the treatment of osteomyelitis. In the present study, V-HEPHAPC (HEPHAPC with vancomycin) granules were used as a vancomycin carrier to treat MRSA osteomyelitis. First, in vivo Good Laboratory Practice (GLP) toxicological tests were performed in a rabbit model, assuring that HEPHAPC and V-HEPHAPC have no relevant side effects. Second, V-HEPHAPC proved to be an efficient drug carrier and bone substitute to control MRSA infection and simultaneously reconstruct the bone cavity in a sheep model. MDPI 2023-02-04 /pmc/articles/PMC9952702/ /pubmed/36829700 http://dx.doi.org/10.3390/bioengineering10020206 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alegrete, Nuno Sousa, Susana R. Padrão, Tatiana Carvalho, Ângela Lucas, Raquel Canadas, Raphael F. Lavrador, Catarina Alexandre, Nuno Gärtner, Fátima Monteiro, Fernando J. Gutierres, Manuel Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title | Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title_full | Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title_fullStr | Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title_full_unstemmed | Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title_short | Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model |
title_sort | vancomycin-loaded, nanohydroxyapatite-based scaffold for osteomyelitis treatment: in vivo rabbit toxicological tests and in vivo efficacy tests in a sheep model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952702/ https://www.ncbi.nlm.nih.gov/pubmed/36829700 http://dx.doi.org/10.3390/bioengineering10020206 |
work_keys_str_mv | AT alegretenuno vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT sousasusanar vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT padraotatiana vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT carvalhoangela vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT lucasraquel vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT canadasraphaelf vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT lavradorcatarina vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT alexandrenuno vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT gartnerfatima vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT monteirofernandoj vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel AT gutierresmanuel vancomycinloadednanohydroxyapatitebasedscaffoldforosteomyelitistreatmentinvivorabbittoxicologicaltestsandinvivoefficacytestsinasheepmodel |